Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion
Nur P. Damayanti(University of Indianapolis), Karen E. Pollok(Indiana University Health), M. Reza Saadatzadeh(Indiana University School of Medicine), Erika A. Dobrota(Indiana University School of Medicine), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Khadijeh Bijangi‐Vishehsaraei(Indiana University School of Medicine), Julia Wulfkuhle(University of California, San Francisco), Karl Balsara(Indiana University Health), Anthony Alfonso(Indiana University Bloomington), Barbara J. Bailey(Indiana University School of Medicine), Kathy Coy(Indiana University Health), Rosa I. Gallagher(George Mason University), Melissa A. Trowbridge(Indiana University Health), Anthony L. Sinn(Indiana University Health), Angela M. Richardson(Broad Institute), Alex Lion(Indiana University School of Medicine), Josue D. Ordaz(Indiana University – Purdue University Indianapolis), Zhong‐Yin Zhang(Purdue University West Lafayette), Mark S. Marshall(Eli Lilly (United States)), Michael J. Ferguson(Indiana University School of Medicine), Harlan E. Shannon(Indiana University School of Medicine), Pankita H. Pandya(Indiana University School of Medicine)
Cited by 1
Related Papers
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
|The Lancet Oncology|2020|541
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
|Cancer Cell|2022|335